Document is current
Any future updates will be listed below
-
Authors
Liu, Qinran https://orcid.org/0000-0001-7090-8485
Zhang, Yiwen https://orcid.org/0000-0002-1193-2263
Vaselkiv, Jane B.
Mucci, Lorelei A.
Giovannucci, Edward L. https://orcid.org/0000-0002-6123-0219
Platz, Elizabeth A. https://orcid.org/0000-0003-3676-8954
Sutcliffe, Siobhan https://orcid.org/0000-0002-4613-8107
- License Information
-
More Information
Article History
Received: 13 October 2023
Revised: 18 January 2024
Accepted: 19 January 2024
First Online: 22 February 2024
Competing interests
: Dr. Mucci reports the following disclosures: she received research funding from Astra Zeneca, Janssen, and Veracyte; was a consultant to Bayer; and is on the SAB and has equity interests in Convergent TX. None of these activities are relevant to the current study. The remaining authors declare no competing interests.
: The study protocol was approved by the institutional review boards of the Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health, as well as those of participating registries as required.
: Not applicable.
